Literature DB >> 19012258

[Cognitive impairment associated to leukoaraiosis: its pathophysiology, clinical manifestations and treatment].

I Jiménez1, J Agulla, M Pouso, M Sabucedo, M Rodríguez-Yáñez, T Sobrino, D Brea, M Blanco, R Leira, J Castillo.   

Abstract

INTRODUCTION AND DEVELOPMENT: Leukoaraiosis is a radiological term which refers to white matter disturbances observed as a hypodensity in computed tomography and hyperintensity in T2-weighted magnetic resonance image. The most accepted theory to explain the mechanism of production of leukoaraiosis is chronic ischemia, due to a damage in penetrating arteries. It is an entity with increasing interest, since it is associated with the presence of cognitive impairment. Clinical manifestations in relation with cognitive functions range from mild affectation to dementia, affecting the processing speed and executive functions.
CONCLUSIONS: It seems that the control of vascular risk factors slow the progression of leukoaraiosis and cognitive impairment, and although there are no really effective treatment, it seems that some drugs, such as acetylcholinesterase inhibitors or NMDA-receptor antagonists, exert a beneficial effect, although slight, in cognitive functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012258

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  2 in total

1.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

2.  Apathy and Leukoaraiosis in Mild Cognitive Impairment and Alzheimer's Disease: Multicenter Diagnostic Criteria according to the Latest Studies.

Authors:  Carmen María Sarabia-Cobo; Victoria Pérez; Carmen Hermosilla; María José Nuñez; Pablo de Lorena
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.